Zejula

Niraparib

7.7 High risk

Zejula & White blood cell count decreased

7.9%

of users reported White blood cell count decreased

77.1%

also reported Severe reaction

99.8%

are women

Most common medical consequences

Severe reaction
77.1%
Hospitalization
15.1%
Life-threatening condition
5.8%
Death
1.2%
Disability
0.8%

Have you experienced any negative side effects from this medication?

Zejula: general information

Most common side effects (321)

Most commonly affected ages

30 - 39 years
0.5%
40 - 49 years
6.1%
50 - 59 years
20.9%
60 - 69 years
35.8%
70 - 79 years
29.1%
80 - 89 years
7.4%
90 - 99 years
0.3%